129 related articles for article (PubMed ID: 35731844)
1. Mapping of PET/CT-based regional nodes distribution of recurrent/advanced breast cancer and comparison with current delineation atlas.
Zhang M; Cao L; Chen J; Li B; Huang X; Cai G; Xu C
Br J Radiol; 2022 Sep; 95(1137):20220382. PubMed ID: 35731844
[TBL] [Abstract][Full Text] [Related]
2. FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
Borm KJ; Voppichler J; Düsberg M; Oechsner M; Vag T; Weber W; Combs SE; Duma MN
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):574-582. PubMed ID: 30118822
[TBL] [Abstract][Full Text] [Related]
3. PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases.
Beaton L; Nica L; Tyldesley S; Sek K; Ayre G; Aparicio M; Gondara L; Speers C; Nichol A
Radiat Oncol; 2020 Jun; 15(1):136. PubMed ID: 32487183
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy.
Turna M; Rzazade R; Canoğlu MD; Küçükmorkoç E; Küçük N; Çağlar HB
Br J Radiol; 2022 May; 95(1133):20211234. PubMed ID: 35084214
[TBL] [Abstract][Full Text] [Related]
5. Optimal Target Delineation and Treatment Techniques in the Era of Conformal Photon and Proton Breast and Regional Nodal Irradiation.
Kowalski ES; Feigenberg SJ; Cohen J; Fellows Z; Vadnais P; Rice S; Mishra MV; Molitoris JK; Nichols EM; Snider JW
Pract Radiat Oncol; 2020; 10(3):174-182. PubMed ID: 31786234
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
7. Infiltration tendency of internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implications for target delineation.
Wang Y; Qi W; Xu H; Zhang M; Han Y; Chen J; Xu C
Radiat Oncol; 2019 Nov; 14(1):208. PubMed ID: 31752910
[TBL] [Abstract][Full Text] [Related]
8. Use of
Davidson T; Ben-David M; Galper S; Haskin T; Howes M; Scaife R; Kanana N; Amit U; Weizman N; Chikman B; Goshen E; Ben-Haim S; Symon Z; Goldstein J
Pract Radiat Oncol; 2017; 7(6):373-381. PubMed ID: 28989000
[TBL] [Abstract][Full Text] [Related]
9. Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
Borm KJ; Oechsner M; Düsberg M; Buschner G; Weber W; Combs SE; Duma MN
Radiother Oncol; 2020 Jan; 142():195-201. PubMed ID: 31540747
[TBL] [Abstract][Full Text] [Related]
10. 2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases.
Shao M; Zi J; Wen G
J Cancer Res Ther; 2018 Sep; 14(Supplement):S661-S666. PubMed ID: 30249884
[TBL] [Abstract][Full Text] [Related]
11. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
Choi WH; Yoo IR; O JH; Kim SH; Chung SK
Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574
[TBL] [Abstract][Full Text] [Related]
12. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B
Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
[TBL] [Abstract][Full Text] [Related]
14. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD
Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Kim WH; Lee SW; Kim HJ; Chae YS; Jeong SY; Jung JH; Park HY; Lee WK
Sci Rep; 2018 Feb; 8(1):3181. PubMed ID: 29453385
[TBL] [Abstract][Full Text] [Related]
16. Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic performance.
Sohn YM; Hong IK; Han K
J Ultrasound Med; 2014 Jun; 33(6):1013-21. PubMed ID: 24866608
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of SUV
Diao W; Tian F; Jia Z
Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
[TBL] [Abstract][Full Text] [Related]
18. Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.
Park J; Byun BH; Noh WC; Lee SS; Kim HA; Kim EK; Choi CW; Lim SM
Clin Nucl Med; 2014 Apr; 39(4):e249-53. PubMed ID: 24152622
[TBL] [Abstract][Full Text] [Related]
19. A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer.
DeSelm C; Yang TJ; Cahlon O; Tisnado J; Khan A; Gillespie E; Powell S; Ho A
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):583-591. PubMed ID: 30367906
[TBL] [Abstract][Full Text] [Related]
20. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
